Inhibition of lipolysis by adiposomes containing glycosylphosphatidylinositol-anchored Gce1 protein in rat adipocytes

Archives of Physiology and Biochemistry

Volumn 116, Issue 1, 2010, Pages 28-41

  Muller, Günter ^a   Wied, Susanne ^a   Jung, Christian ^a   Frick, Wendelin ^a   Biemer Daub, Gabriele ^a  

^a Sanofi Aventis Dt GmbH   (Germany)

Author keywords

Adiposomes; Glycosylphosphatidylinositol; Lipid droplets; Lipolysis; Sulfonylureas

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL;

ADIPOCYTE; ANIMAL; ARTICLE; CELL CULTURE; LIPOLYSIS; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TRANSPORT VESICLE; ULTRASTRUCTURE;

ADIPOCYTES; ANIMALS; CELLS, CULTURED; GLYCOSYLPHOSPHATIDYLINOSITOLS; LIPOLYSIS; RATS; RATS, SPRAGUE-DAWLEY; TRANSPORT VESICLES;

RATTUS;

EID: 77949387075     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813450903508812     Document Type: Article

References (68)

1. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J. (2008). Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nature Cell Biol 10:619-624
2. Anderson SM, Yu G, Giattina M, Miller JL. (1996). Intercellular transfer of a glycosylphosphatidylinositol (GPI)-linked protein: Release and uptake of CD4-GPI from recombinant adeno-associated virus-transduced HeLa cells. Proc Natl Acad Sci USA 93:5894-5898
3. Aoki N, Jin-no S, Nakagawa Y, Asai N, Arakawa E, Tamura N, Tamura T, Matsuda T. (2007). Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox-and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology 148:3850-3862
4. Bastida E, Ordinas A, Escolar G, Jamieson GA. (1984). Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 64:177-184
5. Brown D, London L. (1998). Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111-136
6. Civenni G, Test ST, Brodbeck U, Bütikofer P. (1998). In vitro incorporation of GPI-anchored proteins into human erythrocytes and their fate in the membrane. Blood 9:11784-11792
7. Cocucci E, Racchetti G, Meldolesi J. (2009). Shedding microvesicles: artefacts no more. Trends Cell Biol 19:43-51.
8. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. (2005). Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106:1604-1611
9. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ. (2000). Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113:3365-3374
10. Ducharme NA, Bickel PE. (2008). Lipid droplets in lipogenesis and lipolysis. Endocrinology 149:942-949
11. Dunn DE, Yu J, Nagarajan S, Devetten M, Weichold FF, Medof ME, Young NS, Liu JM. (1996). A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPIanchored proteins. Proc Natl Acad Sci USA 93:7938-7943
12. Eken C, Gasser O, Zenhaeusern G, Oehri I, Hess C, Schifferli JA. (2008). Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. J Immunol 180:817-824
13. Fevrier B, Raposo G. (2004). Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16:415-421
14. Freyssinet J-M. (2003). Cellular microparticles: what are they bad or good for? J Thromb Haemost 1:1655-1662
15. Fritzsching B, Schwer B, Kartenbeck J, Pedal A, Horejsi V, Ott M. (2002). Release and intercellular transfer of cell surface CD81 via microparticles. J Immunol 169:5531-5537
16. Fujimoto T, Ohsaki Y, Cheng J, Suzuki M, Shinohara Y. (2008). Lipid droplets: a classic organelle with new outfits. Histochem Cell Biol 130:263-279
17. Gasser O, Hess C, Miot S, Deon C, Sanchez JC, Schifferli JA. (2003). Characterization and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res 285:243-257
18. Gould SJ, Booth AM, Hildreth JE. (2003). The Trojan exosome hypothesis. Proc Natl Acad Sci USA 100:10592-10597
19. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. (1999). Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94:3791-3799
20. Johnstone RM. (2006). Exosomes biological significance: A concise review. Blood Cells Mol Dis 36:315-321
21. Keller S, Sanderson MP, Stoeck A, Altevogt P. (2006). Exosomes: from biogenesis and secretion to biological function. Immunol Lett 107:102-108
22. Kooyman DL, Byrne GW, Logan JS. (1998). Glycosyl phosphatidylinositol anchor. Exp Nephrol 6:148-151
23. Kooyman DL, Byrne GW, McClellan S, Nielsen D, Tone M, Waldmann H, Coffman TM, McCurry KR, Platt JL, Logan JS. (1995). In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 269:89-92.
24. Lösche W, Scholz T, Temmler U, Oberle V, Claus RA. (2004). Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets 15:109-115
25. McHugh RS, Ahmed SN, Wang YC, Sell KW, Selvavaj P. (1995). Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80). Proc Natl Acad Sci USA 92:8059-8063
26. Medof ME, Kinoshita T, Nussenzweig V. (1984). Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med 160:1558-1578
27. Medof ME, Kinoshita T, Silber R, Nussenzweig V. (1985). Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay accelerating factor. Proc Natl Acad Sci USA 82:2980-2984
28. Medof ME, Nagarajan S, Tykocinski ML. (1996). Cell-surface engineering with GPI-anchored proteins. FASEB J 10:574-586
29. Morgan BP, van der Berg CW, Davies EV, Hallett MB, Horejsi V. (1993). Cross-linking of CD59 and of other glycosyl phosphatidylinositol-anchored molecules on neutrophils triggers cell activation via tyrosine kinase. Eur J Immunol 23:2841-2850
30. Müller G. (2005). The mode of action of glimepiride-beyond insulin secretion. Curr Med Chem 5:499-518.
31. Müller G, Ertl J, Gerl M, Preibisch G. (1997a). Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 272:10585-10593
32. Müller G, Frick W. (1999). Signalling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin. Cell Mol Life Sci 56:945-970
33. Müller G, Hanekop N, Wied S, Frick W. (2002). Cholesterol depletion blocks redistribution of lipid raft components and insulin-mimetic signaling by glimepiride and phosphoinositolglycans in rat adipocytes. Mol Med 8:120-136
34. Müller G, Jordan H, Jung C, Kleine H, Petry S. (2003). Analysis of lipolysis in adipocytes using a fluorescent fatty acid derivative. Biochimie 85:1245-1256
35. Müller G, Jung C, Straub J, Wied S. (2009a). Induced release of membrane vesicles and exosomes from rat adipocytes containing lipid droplet, lipid raft and glycosylphosp hatidylinositol-anchored proteins. Cellular Signalling 21:324-338
36. Müller G, Jung C, Wied S, Biemer-Daub G. (2009b). Induced translocation of glycosylphosphatidylinositol-anchored proteins from lipid droplets to adiposomes in rat adipocytes. Br J Pharmacol 158, 749-770.
37. Müller G, Jung C, Wied S, Biemer-Daub G, Frick W. (2010). Transfer of the glycosylphosphatidylinositol-anchored 5'-nucleotidase CD73 from adiposomes into rat adipocytes stimulates lipid synthesis. Br J Pharmacol, in press.
38. Müller G, Korndörfer A, Saar K, Karbe-Thönges B, Fasold H, Müllner S. (1994a). 4'-amino-benzamido-taurocholic acid selectively solubilizes glycosyl-phosphatidylinositolanchored membrane proteins and improves lipolytic cleavage of their membrane anchors by specific phospholipases. Arch Biochem Biophys 309:329-340
39. 2 and the sulfonylurea drug, glimepiride, in rat adipocytes. Biochemistry 47:1274-1287
40. Müller G, Petry S. (2005). Triacylglycerol, storage and mobilization of human. In: Meyers A, editor. Encyclopedia in Biochemistry and Molecular Biology. Weinheim, Germany: Wiley VCH, vol.14, pp 621-704.
41. Müller G, Schulz A, Wied S, Frick W. (2005). Regulation of lipid raft proteins by glimepiride-and insulin-induced glycosylphosphatidylinositol- specific phospholipase C in rat adipocytes. Biochem Pharmacol 69:761-780
42. Müller G, Wied S. (1993). The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro. Diabetes 42:1852-1867
43. Müller G, Wied S, Crecelius A, Kessler A, Eckel J. (1997b). Phosphoinositolglycan-peptides from yeast potently induce metabolic insulin actions in isolated rat adipocytes, cardiomyocytes and diaphragms. Endocrinology 138:3459-3475
44. Müller G, Wied S, Jung C, Over S. (2008b). Translocation of glycosylphosphatidylinositol-anchored proteins to lipid droplets and inhibition of lipolysis in rat adipocytes is mediated by reactive oxygen species. Br J Pharmacol 154:901-913
45. 2 and the antidiabetic sulfonylurea drug, glimepiride, in rat adipocytes. Eur J Pharmacol 597:6-18.
46. 2 and the sulfonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets. Biochemistry 47:1259-1273
47. 2 and the sulfonylurea drug, glimepiride. Mol Pharmacol 73:1513-1529
48. Müller G, Wied S, Wetekam E-M, Crecelius A, Unkelbach A, Pünter J. (1994c). Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulfonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade. Biochem Pharmacol 48:985-996
49. Nosjean O, Briolay A, Roux, B. (1997). Mammalian GPI proteins: sorting, membrane residence and functions. Biochim Biophys Acta 1331:153-186
50. Pap E, Pallinger E, Pasztoi M, Falus A. (2009). Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 58:1-8.
51. Piccin A, Murphy WG, Smith OP. (2007). Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21:157-171
52. Pluskota E, Woody NM, Szpak D, Ballantyne CM, Soloviev DA, Simon DI, Plow EF. (2008). Expression, activation, and function of integrin aMß2 (Mac-1) on neutrophil-derived microparticles. Blood 112:2327-2335
53. Poste G, Nicolson GL. (1980). Arrest and metastasis of bloodborne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA 77:399-403.
54. Premkumar DR, Fukuoka Y, Sevlever D, Brunschwig E, Rosenberry TL, Tykocinski ML, Medof ME. (2001). Properties of exogenously added GPI-anchored proteins following their incorporation into cells. J Cell Biochem 82:234-245
55. Rifkin MR, Landsberger FR. (1990). Trypanosome variant surface glycoprotein transfer to target membranes: A model for the pathogenesis of trypanosomiasis. Proc Natl Acad Sci USA 87:801-805
56. Rooney IA, Atkinson JP, Krul ES, Schonfeld G, Polakoski K, Saffitz JE, Morgan BP. (1993). Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis. J Exp Med 177: 1409-1420
57. Sloand EM, Maciejewski JP, Dunn D, Moss J, Brewer B, Kirby M, Young NS. (1998). Correction of the PNH defect by GPIanchored protein transfer. Blood 92:4439-4445
58. Stoorvogel W, Kleijmeer MJ, Geuze H, Raposo G. (2002). The biogenesis and functions of exosomes. Traffic 3:321-330
59. Suzuki K, Okumura Y. (2000). GPI-linked proteins do not transfer spontaneously from erythrocytes to liposomes. New aspects of reorganization of the cell membrane. Biochemistry 39:9477-9485
60. Taylor DD, Black PH. (1986). Shedding of plasma membrane fragments. Neoplastic and developmental importance. Dev Biol 3:33-57.
61. Thery C, Zitvogel L, Amigorena S. (2002). Exosomes: composition, biogenesis and function. Nat Rev Immunol 3:569-579
62. Tiede A, Bastisch I, Schubert J, Orlean P, Schmidt RE. (1999). Biosynthesis of glycosylphosphatidylinositols in mammals and unicellular microbes. Biol Chem 380:503-523
63. Vakeva R, Jauhiainen M, Ehnoholm C, Lehto T, Meri S. (1994). High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma. Immunology 82:28-33.
64. van den Berg CW, Cinek T, Hallett MB, Horejsi V, Morgan BP. (1995). Exogenous glycosyl phosphatidylinositol-anchored CD59 associates with kinases in membrane clusters on U937 cells and becomes Ca(2+) signaling competent. J Cell Biol 131:669-677
65. Varma R, Mayor S. (1998). GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394: 798-801.
66. Walter EI, Ratnoff WD, Long KE, Kazura JW, Medof ME. (1992). Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cells. J Biol Chem 267:1245-1252
67. Wolf P. (1967). The nature and significance of platelet products in human plasma. Br J Haematol 13:269-288
68. Zhang F, Schmidt WG, Hou Y, Williams AF, Jacobson K. (1992). Spontaneous incorporation of the glycosyl-phosphatidylinositol-linked protein Thy-1 into cell membranes. Proc Natl Acad Sci USA 89:5231-5235